Paul Edward Kelly
COO, Director · RELMADA THERAPEUTICS, INC.
- 2025
- Dec 16, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul Edward Kelly files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Maged Shenouda - $1.99M in RLMD purchases and sales in the last 12 months
- Sergio Traversa - $1.54M in RLMD purchases and sales in the last 12 months
- Chuck Ence - $299K in RLMD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Edward Kelly?
Paul Edward Kelly is a corporate insider, tracked as COO, Director of RELMADA THERAPEUTICS, INC. (RLMD). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul Edward Kelly last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 2 filings going back to 2025.
Has Paul Edward Kelly been buying or selling stock?
Recorded transactions: 1 open-market purchase ($198K) and 0 open-market sales across all tracked filings.
